Hymenoxin (compound 7) is a dual inhibitor of iNOS and NF-κB with IC50 of 42.7 μM and 85.5 μM respectively. Hymenoxin can inhibit 16% of oxidative stress at a concentration of 125 μg/mL[1].

HYOU1 Human Pre-designed siRNA Set A contains three designed siRNAs for HYOU1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

HYOU1-IN-1 (Compound 33) is an inhibitor of hypoxia-upregulated protein 1 (HYOU1) with anti-inflammatory activity. HYOU1-IN-1 can be used in research on the regulation of fibroblast activation, chronic inflammation, and fibrotic diseases[1].

HYPK Human Pre-designed siRNA Set A contains three designed siRNAs for HYPK gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

I-070 is an agonist for glucagon-like peptide-1 receptor (GLP-1 receptor), with EC50 of 0.0187 nM[1].

I-128 is an agonist for glucagon-like peptide-1 receptor (GLP-1 receptor), with EC50 of 0.0122 nM[1].

I-As-1 is a potent inhibitor of Bruton’s tyrosine kinase (BTK), with the IC50 of 2.35 nM. I-As-1 shows antiproliferative activities among Ramos cells and OCI-LY10 cells with IC50s of 0.52 μM and 0.11 μM, respectively[1].

I-BOP is an agonist for thromboxane A2 receptor (TP) with a KD of 0.61 nM. I-BOP promotes proliferation through activation of PI3K pathway in vascular smooth muscle[1]. I-BOP dose-dependently biphasicly affects the excitatory postsynaptic potential (e.p.s.p.) in hippocampal neurons[2].

I-XW-053 is an inhibitor of HIV-1 capsid protein that can suppress the replication of HIV-189BZ167 with an IC50 value of 164.2 μM. I-XW-053 exhibits antiviral activity and can block the interface between capsid protein (CA) N-terminal domains (NTD-NTD interface) with micromolar affinity[1].

I-XW-053 is an inhibitor of HIV-1 capsid protein that can suppress the replication of HIV-189BZ167 with an IC50 value of 164.2 μM. I-XW-053 exhibits antiviral activity and can block the interface between capsid protein (CA) N-terminal domains (NTD-NTD interface) with micromolar affinity[1].

I-XW-053 is an inhibitor of HIV-1 capsid protein that can suppress the replication of HIV-189BZ167 with an IC50 value of 164.2 μM. I-XW-053 exhibits antiviral activity and can block the interface between capsid protein (CA) N-terminal domains (NTD-NTD interface) with micromolar affinity[1].

IAA/BSA is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of IAA () and BSA. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases[1].

IAH1 Human Pre-designed siRNA Set A contains three designed siRNAs for IAH1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

IAPP Human Pre-designed siRNA Set A contains three designed siRNAs for IAPP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

IARS2 Human Pre-designed siRNA Set A contains three designed siRNAs for IARS2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

IAV-IN-2 (Compound MC-22) inhibits for Influenza A Virus (IAV) through blocking the entry of IAV into host cell via clathrin-mediated endocytosis (CME)[1].

IB-96212 (compound 5) is a member of oligomycin class which can be extracted ftom the marine Micromonospora sp. L-25-ES25-008 ref. IB-96212 is an antitumor antibiotic against P-388, it also exhibits antimicrobial activity against Micrococcus luteus[1].

IBA57 Human Pre-designed siRNA Set A contains three designed siRNAs for IBA57 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Iberverin (-Methylthiopropyl isothiocyanate) is a sulforaphane homolog. Iberverin has anticancer activity. Iberverin inhibits cell proliferation and migration. Iberverin induces mitochondrial-related apoptosis and intracellular reactive oxygen species[1].

Iberverin (-Methylthiopropyl isothiocyanate) is a sulforaphane homolog. Iberverin has anticancer activity. Iberverin inhibits cell proliferation and migration. Iberverin induces mitochondrial-related apoptosis and intracellular reactive oxygen species[1].

IBG3 is a dual-JQ1-containing BET degrader that targets protein degradation via intramolecular bivalent glues. IBG3 is a BRD2 and BRD4 bifunctional degrader with DC50 values of 8.6 pM and 6.7 pM, respectively[1].

Ibrexafungerp (MK 3118) is an orally active β-1,3-glucan synthesis inhibitor, with potential antifungal activity. Ibrexafungerp can be used for research of Candida and Aspergillus infections[1].

IBSP Human Pre-designed siRNA Set A contains three designed siRNAs for IBSP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

IBTK Human Pre-designed siRNA Set A contains three designed siRNAs for IBTK gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Ibutilide (fumarate) (Standard) is the analytical standard of Ibutilide (fumarate). This product is intended for research and analytical applications. Ibutilide (U70226E) fumarate, an action potential-prolonging antiarrhythmic, is a potent blocker of the rapidly activating delayed rectifier K+ current (IKr) in AT-1 cells[1].

ICA1 Human Pre-designed siRNA Set A contains three designed siRNAs for ICA1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ICAM1 Human Pre-designed siRNA Set A contains three designed siRNAs for ICAM1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ICAM2 Human Pre-designed siRNA Set A contains three designed siRNAs for ICAM2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ICAM3 Human Pre-designed siRNA Set A contains three designed siRNAs for ICAM3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ICAM4 Human Pre-designed siRNA Set A contains three designed siRNAs for ICAM4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ICAM5 Human Pre-designed siRNA Set A contains three designed siRNAs for ICAM5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ICE1 Human Pre-designed siRNA Set A contains three designed siRNAs for ICE1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ICE2 Human Pre-designed siRNA Set A contains three designed siRNAs for ICE2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ICI-63197 is a phosphodiesterase 3 (PDE3) and PDE4 inhibitor with Ki values of 9 µM and 10 µM, respectively. ICI-63197 is selectivity against PDE1 and PDE2. ICI-63197 has antidepressant effects[1][2].

ICL-CCIC-0019 is an inhibitor of choline kinase α (CHKα). ICL-CCIC-0019 induces G1 block, endoplasmic reticulum stress apoptosis in cancer cell lines[1].

ICMT Human Pre-designed siRNA Set A contains three designed siRNAs for ICMT gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Icopezil is a selective acetylcholinesterase (AchE) inhibitor. Icopezil can be used in Alzheimer’s disease research[1].

ICOS Human Pre-designed siRNA Set A contains three designed siRNAs for ICOS gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ICOSLG Human Pre-designed siRNA Set A contains three designed siRNAs for ICOSLG gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ID1 Human Pre-designed siRNA Set A contains three designed siRNAs for ID1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ID2 Human Pre-designed siRNA Set A contains three designed siRNAs for ID2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ID3 Human Pre-designed siRNA Set A contains three designed siRNAs for ID3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ID4 Human Pre-designed siRNA Set A contains three designed siRNAs for ID4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

IDD-8E is an effective anti-pseudomonal agent (MIC =4.4 µM ) with no cytotoxicity. IDD-8E shows significant pseudomonal killing and disruption of pseudomonal biofilm. IDD-8E binds to the ATP-binding pocket of WaaP and also inhibits other ESKAPE pathogens. [1]